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Background: Previous theory and research suggest links between substance use and externalizing
behavior problems, but links between substance use and internalizing problems are less clear. The
present study sought to understand concurrent links among diagnoses of substance use disorders,
internalizing disorders, and behavior disorders at age 18 as well as developmental trajectories of illicit
substance use prior to and after this point. Methods: Using data from 585 participants in the
Child Development Project, this study examined comorbidity among substance use, behavior, and
internalizing disorders at age 18 and trajectories of growth in illicit substance use from age 12 to age
22. Results: In this community sample, meeting diagnostic criteria for comorbid internalizing dis-
orders, a behavioral disorder (conduct disorder or oppositional defiant disorder) alone, or both inter-
nalizing and behavioral disorders predicted higher concurrent substance use disorders (abuse,
dependence, or withdrawal). Meeting diagnostic criteria for an anxiety disorder alone or depression
alone did not predict higher concurrent substance use diagnoses. Over time, youths with behavioral
disorders at age 18 showed a pattern of increasing substance use across early adolescence and higher
levels of substance use than those with no diagnosis at age 18. Substance use declines from late
adolescence to early adulthood were observed for all groups. Conclusions: Substance use disorders
were more highly comorbid with behavior disorders than with internalizing disorders at age 18, and
behavior disorder and comorbid behavior-internalizing disorders at age 18 were related to trajectories
characterized by steep increases in illicit substance use during adolescence and high rates of illicit
substance use over time. Keywords: Comorbidity, behavior disorders, externalizing disorders, inter-
nalizing disorders, substance use.
Substance use during adolescence and early adult-
hood is of considerable concern to parents, policy-
makers, and researchers alike, both because of the
immediate risks posed by substance use itself (e.g.,
increased risk of motor vehicle accidents or unsafe
sexual behavior while under the influence of sub-
stances) and because of the long-term negative
consequences that may accrue from patterns of
substance use over time. For example, even occa-
sional, light users of marijuana are less likely to
graduate from college, are more likely to engage in
delinquent behaviors such as violence and stealing,
and report poorer physical health than do abstain-
ers; heavier and more regular users are at risk
of even more serious problems (Tucker, Ellickson,
Orlando, Martino, & Klein, 2005). By the 12th grade,
46% of adolescents have tried marijuana (Johnston,
O’Malley, Bachman, & Schulenberg, 2004), and 9%
of 12–17-year-olds are diagnosed with substance
use disorders (Substance Abuse and Mental Health
Services Administration, 2004), suggesting that
problems associated with substance use are
prevalent. The present study had two main goals.
First, we sought to understand concurrent links
among diagnoses of age 18 substance use disorders,
internalizing disorders, and behavior disorders.
Second, we sought to examine relations between
diagnoses of internalizing and behavior disorders at
age 18 and developmental trajectories of substance
use both prior to and after this point.
Comorbidity between substance use and other
disorders
Until recently, comorbidity during adolescence was
studied primarily in clinical populations, which
posed a set of challenges in interpreting the research
findings (Armstrong & Costello, 2002). In particular,
because individuals with more than one problem are
more likely to seek treatment than are individuals
with just one problem, the prevalence rates for
comorbidity assessed in clinical samples may exceed
those in the broader population, and certain com-
binations of disorders may lead individuals to seek
treatment more often than other combinations,
again leading to misperceptions if one attempts to
generalize to non-clinical samples (Armstrong &
Costello, 2002). Recently, however, a substantialConflict of interest statement: No conflicts declared.
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body of literature on adolescents in community
samples has shown that higher levels of externaliz-
ing problems are related to more substance use
(Costello, 2007). For example, in a group of rural
adolescents followed for 42 months starting at the
age of 12 years, those adolescents who initially
showed higher levels of externalizing problems were
more likely to initiate substance use over time
(Lillehoj, Trudeau, Spoth, & Madon, 2005). Sim-
ilarly, Fergusson, Horwood, and Ridder (2007) found
that conduct problems as early as ages 7–9 years
predicted substance use, abuse, and dependence in
young adulthood.
Problem-behavior theory (Jessor & Jessor, 1977)
would suggest that social controls that inhibit one
set of problem behaviors (e.g., substance use) may
be the same social controls that inhibit other sets of
problem behaviors (e.g., externalizing problems). In
addition, individual differences in proneness to
problem behavior may involve attitudes, beliefs, and
expectations such as greater tolerance of deviance or
lower value on educational achievement that extend
across domains of problem behaviors (Jessor &
Jessor, 1977). Furthermore, engagement in different
kinds of problem behaviors might be perpetuated by
involvement in a deviant peer group that provides
both opportunities and motivation to engage in such
behaviors (e.g., Dishion, Andrews, & Crosby, 1995).
Therefore, there are good theoretical reasons to
expect comorbidity between substance use disorders
and other kinds of behavior disorders.
Empirical findings with respect to links between
substance use and internalizing problems are less
consistent than those for links between substance
use and behavior problems. For example, Neighbors,
Kempton, and Forehand (1992) found that sub-
stance use among juvenile delinquents was related
to more symptoms of anxiety and depression.
Wittchen et al. (2007) found that even after control-
ling for externalizing disorders, internalizing dis-
orders (depressive and bipolar disorders, and
anxiety less consistently) predicted subsequent
marijuana use. Furthermore, Hallfors, Waller, Bau-
er, Ford, and Halpern (2005) found that substance
use predicted future depression. Yet other studies
have reported no association between substance use
and internalizing problems (Windle & Wiesner,
2004). Still other studies have found that internal-
izing problems are related to less substance use. For
example, Steele, Forehand, Armistead, and Brody
(1995) found that for boys, higher internalizing
scores in early adolescence predicted less marijuana
and hard substance use in young adulthood.
Two main theories have been posited in the litera-
ture that could account for these discrepant findings.
The self-medication theory (e.g., Khantzian, 1985) is
that individuals who are anxious, depressed, or both
may attempt to assuage their negative emotions by
turning to substances (e.g., to make themselves feel
more relaxed). This theory would, therefore, predict a
positive correlation between higher levels of inter-
nalizing problems and more substance use. A risk-
avoidance theory (e.g., Wills, Windle, & Cleary,
1998), on the other hand, would predict that higher
levels of internalizing problems would be related to
less substance use because individuals who are
anxious are more likely to fear taking risks (including
risks related to using substances) and are less likely
to be in social situations that would be conducive
to using substances (see Siebenbruner, Englund,
Egeland, & Hudson, 2006).
Trajectories of substance use over time
Several studies have documented trajectories of
smoking (e.g., Chassin, Presson, Pitts, & Sherman,
2000) and binge drinking (Hill, White, Chung, Haw-
kins, & Catalano, 2000) during adolescence and
early adulthood. There have been fewer studies of
trajectories of illicit substance use. Most studies
of illicit substance use have either included cross-
sectional data or have included just two waves of
data in a longitudinal design (Windle & Wiesner,
2004). However, there are some notable exceptions
(Kandel & Chen, 2000; Newcomb & Bentler, 1989).
Windle and Wiesner (2004) analyzed four waves of
data during adolescence and identified five trajectory
groups that characterized different patterns of
marijuana use: Abstainers, Experimental Users,
Decreasers, Increasers, and High Chronics. Simi-
larly, Connell, Dishion, and Deater-Deckard (2006)
also found five trajectory groups when they tracked
patterns of substance use in 698 adolescents for four
years from Grade 6 to Grade 9: (1) no use, (2) low/
rare use, (3) early accelerating use, (4) late-acceler-
ating use, and (5) early high but decreasing use. Guo
et al. (2002) identified four distinct trajectories of
marijuana use from age 13 to 18: early highs, esca-
lators, late onsetters, and nonusers. Ellickson,
Martino, and Collins (2004) followed 5,833 individ-
uals from the age of 13 to 23 and also found four
trajectory groups of marijuana use (in addition to
abstainers): early high users (who had high levels of
use at age 13 and who decreased to a moderate level
over time), stable light users (who consistently
showed low levels of use), steady increasers (who
increased use over time), and occasional light users
(who initiated use at age 14 and continued to use at
low levels over time).
The present study
The present study addressed two primary research
questions using data from a multisite community
sample followed from age 12 to 22. The first question
was to what extent behavior disorders, anxiety dis-
orders, depressive disorders, and substance use
disorders are comorbid at age 18. On the basis of
previous research, we hypothesized that behavior
disorders and substance use disorders would show a
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great deal of comorbidity. However, the nature of the
association between internalizing disorders and
substance use disorders is less clear from the extant
literature, in which the samples have differed in age
and gender composition, substances used, and
operationalization of internalizing problems. We
were able to test alternate hypotheses suggested
by the self-medication theory that internalizing
disorders would be comorbid with substance use
disorders and the risk-avoidance theory that inter-
nalizing disorders would not be comorbid with sub-
stance use disorders. The second question was how
developmental trajectories of substance use from age
12 to age 22 are related to diagnoses of behavior and
internalizing disorders at age 18. We hypothesized
that behavior disorders would be associated with
higher levels of illicit substance use in adolescence
and an increase in illicit substance use over the
adolescent years. As with the first research question,
we were able to test alternate hypotheses regarding
the links between internalizing disorders and
trajectories of illicit substance use.
Method
Participants
The families in the current investigation were particip-
ants in an ongoing, multisite longitudinal study of
child development (Dodge, Bates, & Pettit, 1990).
Participants were recruited when the children entered
kindergarten in 1987 or 1988 at three sites: Knoxville
and Nashville, TN and Bloomington, IN. Parents were
approached at random during kindergarten pre-regis-
tration and asked if they would participate in a longit-
udinal study of child development. About 15% of
children at the targeted schools did not pre-register.
These participants were recruited on the first day of
school or by subsequent contact. Of those asked,
approximately 75% agreed to participate. The sample
consisted of 585 families at the first assessment in
kindergarten. Males comprised 52% of the sample.
Eighty-one percent (81%) of the sample were European
American, 17% were African American, and 2% were
from other ethnic groups. Follow-up assessments were
conducted annually through age 22. Seventy-nine per-
cent of the original 585 families provided age 22 data,
but the sample of 535 for the growth curve analyses
included 91% of the original sample that provided data
on illicit substance use in at least one year between the
age of 12 and 22. The 535 participants were of higher
SES in kindergarten than were the 50 original particip-
ants who did not provide illicit substance use data,
t(568) = 2.42, p < .05 and were more likely to be female,
v2(1) = 7.12, p < .01; but these two groups did not differ
significantly by ethnicity. IRB approval was granted,
and participants provided informed consent at each
wave of data collection.
Procedures and measures
Psychiatric diagnoses. At the age of 18, the National
Institute of Mental Health Diagnostic Interview
Schedule was administered to participants during an
in-person assessment by a trained interviewer in order
to measure young adult psychiatric symptoms and
DSM-IV diagnoses. Interviewers recorded participants’
responses in a computer program designed to handle
complicated skip patterns that were invoked depend-
ing on participants’ responses to each question (e.g.,
follow-up questions about specific aspects of a dis-
order were skipped if the participant did not meet the
diagnostic criteria for having the disorder). A large
number of studies have examined the psychometric
properties of the DIS. In general, these show accept-
able convergent validity (e.g., Fantoni-Salvador &
Rogers, 1997) and good to excellent reliability (e.g.,
Hasin et al., 2006).
Participants were classified with an anxiety disorder
at age 18 if they met diagnostic criteria for any of
the following disorders: specific phobia, panic attack,
social phobia, agoraphobia, generalized anxiety, post-
traumatic stress, obsessive compulsive, or separation
anxiety. Depressive diagnoses included major depres-
sive disorder and dysthymic disorder. Behavior problem
diagnoses included oppositional defiant disorder and
conduct disorder.
Substance use. Illicit substance use data for the
present study were collected at ages 12, 16, 17, 18, 21,
and 22. At age 12, adolescents were asked how many
times in the last year they (a) smoked marijuana; and
(b) used other drugs. Each item was rated on an 8-point
scale (0 = never, 1 = once or twice, 2 = once every
2–3 months, 3 = once a month, 4 = once every
2–3 weeks, 5 = once a week, 6 = 2–3 times a week,
7 = once a day). At ages 16–18 and 21–22, adolescents
indicated whether in the past 12 months they had
smoked marijuana, huffed or inhaled a substance, tried
cocaine or crack, tried LSD or heroin, or tried any other
way to get high (0 = no, 1 = yes). These measures were
combined to create an indicator of illicit substance use
(i.e., use of inhalants, marijuana, or other illegal drugs)
in each year. Illicit substance use was coded ‘0’ if
participants reported no illicit substance use in the past
year, ‘1’ if they reported marijuana use in the past year,
and ‘2’ if they reported using marijuana and at least one
additional illicit substance in the past year. The three-
point form of this variable was selected to yield a com-
parable indicator across years, given the variability in
the measurement forms.
Participants were classified with an illicit substance
use disorder at age 18 if they met diagnostic criteria for
any of the following disorders on the Diagnostic Inter-
view Schedule (DIS): Withdrawal, dependence, or abuse
of marijuana, amphetamines, cocaine, opiates, sedat-
ives, hallucinogens, inhalants, or PCP.
Analysis plan
We began by examining comorbidity of illicit substance
use disorders and internalizing and behavior disorders
by presenting descriptive statistics and chi-square
tests. These initial analyses included the diagnostic
measure of illicit substance use (DIS), whereas sub-
sequent analyses included the continuous, three-point
measure of illicit substance use. We next examined
correlations among illicit substance use variables and
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correlations between illicit substance use and gender
and ethnicity over time from age 12 to age 22. We then
conducted growth curve analyses of illicit substance
use from age 12 to age 22. First, we investigated the
time course of illicit substance use from age 12 to age
22 by fitting an unconditional latent growth curve
model using the Mplus statistical program (Muthén &
Muthén, 2004). Second, we examined demographic
and diagnostic covariates of illicit substance use by
fitting a conditional latent growth curve model.
Participants with substance use data for at least one
year were included in these analyses (n = 535). Mplus
uses full information maximum-likelihood estimation
to generate unbiased parameter estimates and appro-
priate standard errors for respondents with random
missing data (Muthén & Muthén, 1998). Because
internalizing and behavior disorders were diagnosed at
age 18, time was centered at age 18 for all growth
curve analyses.
Results
Diagnostic comorbidity at age 18
The numbers of participants who met diagnostic
criteria for illicit substance use disorders and vari-
ous internalizing and behavior disorders at age 18
are shown in Table 1. In addition, the rates of illicit
substance use disorders among participants with no
internalizing or behavioral diagnosis, anxiety only,
depression only, comorbid internalizing disorders
(i.e., anxiety and depression), behavior disorder only,
and comorbid behavior-internalizing disorders (i.e.,
behavior disorder and anxiety or depression) are
presented in Table 1. Overall, 66% of participants
who met criteria for a substance use disorder also
met criteria for at least one internalizing or behavior
disorder, and 23% of participants with an internal-
izing or behavior disorder also met criteria for a
substance use disorder.
Chi-square analysis revealed significant differ-
ences in the rates of substance use disorders among
participants with different internalizing or behavior
disorders, v2(5, n = 449) = 42.97, p < .001. As
shown in Table 1, the likelihood of a substance use
diagnosis among participants with anxiety only,
v2(1, n = 321) = .23, ns, and depression only,
v2(1, n = 308) = .26, ns, was not significantly differ-
ent from the likelihood of a substance use diagnosis
among participants with no internalizing or behav-
ioral diagnosis. The likelihood of a substance use
diagnosis was elevated among participants with
comorbid internalizing disorders, v2(1, n = 311) =
6.28, p < .05, behavior disorder, v2(1, n = 326) =
19.15, p < .001, and comorbid behavior-internaliz-
ing disorders, v2(1, n = 331) = 35.69, p < .001,
compared to participants with no internalizing or
behavior diagnosis. In other words, comorbid inter-
nalizing and behavior disorder diagnoses were
associated with a higher likelihood of substance use
disorder, but anxiety or depression alone did not
significantly increase the likelihood of a substance
use disorder.1
Correlations among demographic and substance
use variables over time
Means, standard deviations, and correlations among
illicit substance use variables at each time point are
shown in Table 2. Illicit substance use was relatively
stable across time. Correlations in contiguous years
ranged from .64 to .70, and cross-year correlations
ranged from .14 to .58. The mean level of illicit
substance use across all participants was relatively
low at age 12 (M = .07), increased substantially
between ages 12 and 16 (M = .46) to age 18 (M = .56),
Table 1 Comorbidity among substance use, behavior, and










(n = 56) Chi-square2
No diagnosis
(n = 287)
268 (93%) 19 (7%) –
Anxiety only
(n = 34)
31 (91%) 3 (9%) .23
Depression only
(n = 21)




19 (79%) 5 (21%) 6.28*
Behavior disorder
only (n = 39)




28 (64%) 16 (36%) 35.69***
Note. n = 449. Overall Pearson v2(5) = 42.97. p < .001.
1Substance diagnoses included withdrawal, dependence, and
abuse of marijuana, amphetamines, cocaine, opiates, seda-
tives, hallucinogens, and inhalants. Substance diagnoses did
not include alcohol disorders. 2Pearson chi-square analyses
tested whether the likelihood of a substance use disorder at
age 18 differed between participants with no internalizing or
behavioral diagnosis at age 18 and participants within each
diagnostic group at age 18.
1Chi-square analyses also revealed significant differences in
rates of alcohol use disorders (withdrawal, dependence,
abuse), assessed via the DIS, among participants with different
behavior or internalizing disorders, v2(5, n = 441) = 31.09,
p < .001. The likelihood of an alcohol use diagnosis among
participants with anxiety only, v2(1, n = 314) = .00, ns, and
depression only, v2(1, n = 301) = .04, ns, was not significantly
different from the likelihood of a substance use diagnosis
among participants without an internalizing or behavior
diagnosis. The likelihood of an alcohol use diagnosis was
elevated among participants with comorbid internalizing dis-
orders, v2(1, n = 305) = 3.89, p < .05, behavior disorder,
v2(1, n = 320) = 17.01, p < .001, and comorbid behavior-
internalizing disorders, v2(1, n = 325) = 21.08, p < .001, com-
pared to participants without an internalizing or behavior
diagnosis.
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then decreased slightly by age 21 (M = .46) and age
22 (M = .52).
Demographic correlations revealed that males
reported higher levels of substance use at ages 21
and 22 than females. European Americans reported
higher levels of substance use at age 18 than ethnic
minorities.
Growth curve analysis of illicit substance use from
age 12 to age 22
Unconditional baseline model. Linear and quad-
ratic models were initially fit. A delta chi-square
analysis revealed that the model including a
quadratic slope fit the data better than the model
including an intercept and linear slope only
v2(4, N = 535) = 178.83, p < .001. Thus, the uncon-
ditional growth model of illicit substance use from
ages 12 to 22 included three growth parameters:
(1) an intercept parameter centered at age 18, (2) a
linear slope parameter representing the rate of linear
change over time, and (3) a quadratic parameter
representing nonlinear change over time. The inter-
cept, slope, and quadratic growth parameters were
allowed to covary.
As shown in Table 3, the baseline latent growth
model for illicit substance use fit the data well: v2(9,
N = 535) = 23.08, comparative fit index (CFI) = .99,
Tucker Lewis index (TLI) = .98, and root-mean-
square error of approximation (RMSEA) = .054. The
average intercept (.148, p < .001), average slope
(.006, p < .001), and average quadratic slope (–.003,
p < .001) were each significantly different from zero,
indicating that illicit substance use was greater than
zero at age 18, increased over the years of investi-
gation, and declined in early adulthood. Significant
variance existed in both the intercept and quadratic
slope factors but not in the linear slope factor (see
Table 3); thus, the conditional growth model tested
demographic and diagnostic covariates of the inter-
cept and quadratic slope factors but not the linear
slope factor.
Conditional growth model. Conditional latent
growth models were fit to test whether demographic
and diagnostic variables were associated with vari-
ances in the intercept and quadratic slope factors.
Delta chi-square tests compared the fit of the model
with covariates estimated versus covariates con-
strained to zero. Demographic covariates were estim-
ated first, followed by diagnostic covariates.
Estimating demographic covariates of the intercept
improved model fit, v2(2, N = 535) = 25.06, p < .001,
compared to the model with all covariates con-
strained to zero. Estimating diagnostic covariates of
the intercept and quadratic slope further improved
model fit, v2(9, N = 535) = 68.26, p < .001, compared
to the model with demographic covariates of the
intercept estimated and diagnostic covariates con-
strained to zero.2
As shown in Table 3, the set of demographic and
diagnostic variables accounted for 18.0% of the
variance in the intercept of illicit substance use and
24.1% of the variance in the quadratic slope of illicit
substance use. The conditional model fit the data
well, v2(35, N = 535) = 67.83, comparative fit
index (CFI) = .97, Tucker Lewis index (TLI) = .95,
and root-mean-square error of approximation
(RMSEA) = .04.
Gender (male), depression, behavior disorder, and
comorbid behavior-internalizing disorders were
Table 2 Correlations among substance use variables from age 12 to age 22
Variables 1 2 3 4 5 6 7 8
1. Gender –
2. Ethnicity – –
3. Age 12 substance use ).08 ).03 –
4. Age 16 substance use ).01 ).05 .22*** –
5. Age 17 substance use ).05 ).08 .23*** .68*** –
6. Age 18 substance use ).09 ).13** .18*** .58*** .70*** –
7. Age 21 substance use ).16** ).07 .15** .43*** .48*** .51*** –
8. Age 22 substance use ).16*** ).07 .14** .42*** .48*** .45*** .64*** –
Mean – – .07 .46 .52 .56 .46 .52
Standard deviation – – .28 .66 .73 .73 .68 .68
n 585 585 427 458 422 443 464 466
Note. ns for correlations range from 364 to 466. Illicit substance use was coded as 0 = none, 1 = marijuana use, 2 = marijuana plus
other illicit substance. Substance use scores were log-transformed for analyses. Male coded as 0 and female coded as 1.
European American coded as 0 and ethnic minority coded as 1. *p < .05, **p < .01, ***p < .001.
2Standard errors of the model could not be computed when
anxiety, depression, and comorbid internalizing were included
as covariates of the quadratic slope. We conducted an analysis
to test whether fixing these estimates to zero would misrepre-
sent the data. The model included the same three growth
parameters (i.e., intercept, linear slope, quadratic slope) and
anxiety, depression, and comorbid internalizing diagnoses as
covariates of the quadratic slope (excluding these diagnostic
variables as covariates of the intercept, and excluding behavior
disorder and comorbid behavior-internalizing diagnoses as
covariates of the intercept and quadratic slope). This simpler
analysis allowed the model to fit the data, and revealed that
anxiety, depression, and comorbid internalizing were not sig-
nificantly associated with the quadratic slope. Therefore, these
estimates were fixed to zero in the final model.
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each significantly associated with higher illicit
substance use at age 18 (intercept). In addition,
behavior disorder and comorbid behavior-internal-
izing disorders were significantly associated with
the quadratic slope (see Table 3). As illustrated
in Figure 1, participants with no diagnosis, anxiety
only, depression only, and comorbid internalizing
diagnoses showed a similar trajectory of substance
use characterized by a mild increase followed by a
mild decline from adolescence through young
adulthood. Participants with behavior disorders
and comorbid behavior-internalizing disorders
showed a trajectory of steep increases in substance
use across the adolescent years, reaching relatively
high levels of substance use in late adolescence,
and a relatively steep decline in substance use by
young adulthood. On average, adolescents with a
behavior disorder (alone or comorbid with an
internalizing disorder) used either marijuana or
some other illicit substance by age 18. Despite their
steeper decline in substance use during young
adulthood, participants with comorbid behavior-
internalizing disorders at age 18 reported signifi-
cantly higher levels of substance use at age 22 than
did participants with no internalizing or behavioral
diagnosis at age 18, F(1, 299) = 5.96, p < .05. No
other diagnostic groups reported significantly
higher substance use at age 22 than did particip-
ants with no internalizing or behavioral diagnosis at
age 18.3
Discussion
Overall, we found that substance use disorders were
more highly comorbid with behavior disorders than
with internalizing disorders at age 18, and behavior
disorder and comorbid behavior-internalizing dis-
orders at age 18 were related to trajectories charac-
terized by steep increases in illicit substance use
during adolescence and high rates of illicit sub-
stance use over time. The patterns of comorbidity
that we found are similar to those reported in other
studies. For example, 66% of our participants who
met criteria for a substance use disorder also met
criteria for an internalizing or behavioral disorder,
compared to 60% of the participants in Armstrong
and Costello’s (2002) meta-analysis of comorbidity in
community samples.
Our growth model results showed that depression
was associated with higher levels of substance use at
age 18. The chi-square results showed that having a
depressive disorder plus an anxiety disorder was
associated with slightly higher rates of substance
use disorder. In contrast, anxiety alone was not
associated with higher levels of substance use or
higher rates of substance use disorders. Co-occur-
rence of depressive disorders and substance use also
has been more frequently reported in previous
studies than has co-occurrence of anxiety disorders
and substance use (e.g., King, Iacono, & McGue,
2004). It is possible that the self-medication theory
better explains links between depression and sub-
stance use than anxiety and substance use. That is,
individuals who are depressed may be more likely to
use substances to self-medicate unless they are also
anxious and fearful of taking risks (such as using
drugs or merely attending social events where drugs
are likely to be available). It is important to note that
self-medication theory not only posits that self-
medication is an effort to feel better but that there
will be links between specific types of disorders and
specific medications (e.g., depressed individuals will
Table 3 Associations among internalizing and behavioral
diagnoses and growth in illicit substance use from age 12 to
age 22
Growth parameters for illicit sub-
stance use1
Unconditional Model Intercept Quadratic Slope
M (SE ) .148 (.007)*** ).003 (.000)***
Variance (SE ) .020 (.002)*** .001 (.000)***
Demographic variables
Gender2 ).038 (.014)*** .000 (.001)
Ethnicity3 ).034 (.018) .000 (.001)
Diagnostic variables4
Anxiety only .014 (.019) –
Depression only .051 (.024)* –
Comorbid internalizing .040 (.023) –
Behavior disorder only .131 (.025)*** ).005 (.001)***
Comorbid behavior-
internalizing
.162 (.024)*** ).005 (.001)***
M (SE ) .139 (.011)*** ).001 (.000)***
Res variance (SE ) .017 (.002)*** .000 (.000)***
R2 .180 .241
Note. N = 535. Fit of unconditional model: v2 (9) = 23.08,
CFI = .99, TLI = .98, RMSEA = .054. Fit of model with predic-
tors: v2 (35) = 67.83, CFI = .97, TLI = .95, RMSEA = .042.
Demographic and diagnostic variables were not included in
the model as covariates of the linear slope because the variance
of the linear slope was non-significant in the unconditional
growth model, M (SE) = .006 (.001), p < .001; Variance = .000
(.000), ns. 1Illicit substance use measured as 0 = none,
1 = marijuana use, 2 = marijuana plus other illicit substance.
2Male coded as 0; female coded as 1. 3European American
coded as 0; ethnic minority coded as 1. 4No diagnosis coded as
0; diagnosis coded as 1. *p < .05, **p < .01, ***p < .001.
3Continuous measures of teacher-reported externalizing and
internalizing behaviors in childhood were also tested as pre-
dictors of illicit substance use trajectories from ages 12 to 22.
Externalizing behavior at age 5 was associated with the inter-
cept and quadratic slope of illicit substance use, and exter-
nalizing behavior at age 12 was associated with the intercept of
illicit substance use; estimates were in the same direction as
the behavior disorder covariate. However, when these earlier
measures of externalizing behavior were included in the growth
model with the more proximal diagnostic covariates, earlier
externalizing behavior was not significantly associated with
substance use growth parameters. Internalizing behavior at
ages 5 and 12 was not significantly associated with substance
use growth parameters in models with or without diagnostic
covariates.
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choose stimulating drugs, whereas anxious individ-
uals will choose tranquilizing or sedating drugs;
Khantzian, 1985). Our aggregate measure of any
illicit substance use did not distinguish between
different types of substances. Future research that
includes separate indicators of different kinds of
substances will be able to address the aspect of self-
medication theory that posits selection of substances
linked with specific disorders.
An alternate interpretation of the link between
depression and illicit substance use is that depres-
sion can be a consequence of social problems
resulting from externalizing behaviors, which would
include the effects of using illicit substances. With
respect to anxiety, it is possible that if some anxious
people use illicit substances and others do not, self-
medication and risk avoidance mechanisms may
cancel one another out. It is also possible that anx-
iety and substance use are simply unrelated during
this developmental period.
Our findings were similar to those of other studies
showing links between substance use and behavior
problems, particularly conduct disorders (e.g., Sung,
Erkanli, Angold, & Costello, 2004). Examining tra-
jectories of illicit substance use both before and after
psychiatric diagnoses is consistent with the idea that
psychiatric disorders are predictors as well as con-
sequences of substance use (Measelle, Stice, &
Hogansen, 2006). Trajectories of substance use for
individuals with behavior disorders and comorbid
behavior-internalizing disorders were especially
notable in our study for their steep increases in
substance use across the adolescent years. By the
age of 18, individuals who were diagnosed as having
a behavior disorder (alone or comorbid with an
internalizing disorder) showed a trajectory of illicit
substance use across adolescence that was consid-
erably higher than those individuals who were
not diagnosed as having a behavior or internalizing
disorder at age 18.
Initially, the declines we found in substance use in
early adulthood (age 21–22) may seem surprising,
but this pattern is consistent with findings using
data from the Monitoring the Future study, which
also show decreasing substance use in early adult-
hood (Bachman et al., 2002). Bachman et al. suggest
that new responsibilities involving marriage, preg-
nancy, and parenthood in early adulthood may lead
to declines in substance use. The steeper decline in
substance use we found in early adulthood for the
groups with behavior disorders and comorbid
behavior-internalizing disorders may be related to a
decline in externalizing behaviors in early adulthood
among these participants.
One limitation of our study is that our measure of
illicit substance use over time focused just on
whether the individual had used marijuana or any
other illicit substances within a 12-month period.
Frequency of use and problematic use (e.g., addic-
tion, dependency, withdrawal) are also important
features in understanding the developmental course
of illicit substance use (Glantz & Pickens, 1992);
future research that incorporates these different
aspects of illicit substance use will complement the
perspective offered in the present study. In addi-
tion, although abuse of prescription drugs may
have been reported by participants under the gen-
eral question of having tried ‘any other way to get
high,’ we did not ask specifically about the use of
prescription drugs for nonmedical reasons. Nearly
25% of high school seniors have used prescription
drugs without medical supervision according to the
latest data from the Monitoring the Future study
(Johnston, O’Malley, Bachman, & Schulenberg,
2007), making this an important topic for future
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Figure 1 Growth in illicit substance use from age 12 to age 22 by diagnostic status. Illicit substance use was coded
as 0 = none, 1 = marijuana use, 2 = marijuana plus other illicit substance
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was limited primarily to European Americans and
African Americans so the findings may not gener-
alize to individuals from other racial, ethnic, or
cultural groups. Finally, although the CDIS-IV is a
well-validated tool for assessing psychiatric dia-
gnoses that makes sense to use with a large com-
munity sample when it is not possible to have
clinical psychologists or psychiatrists conduct
in-depth interviews to make diagnoses, it is possible
that clinicians could have reached different con-
clusions about the diagnoses of the participants.
One implication of these findings is that com-
orbidity of substance use and other types of dis-
orders should be taken into account when planning
preventive interventions or treatment approaches. In
particular, given the high rates of co-occurrence
between substance use and conduct disorders, it is
reasonable to ask whether an intervention designed
to prevent conduct disorders may also prevent sub-
stance use disorders or vice versa (see Glantz, 2002).
On the other hand, given the more limited
co-occurrence between substance use and internal-
izing disorders, preventive interventions and treat-
ments may need to be tailored more specifically to
these different problems rather than expecting that
a single intervention would reduce both. Future
research could evaluate these possibilities empiri-
cally in the context of longitudinal studies of early
preventive interventions.
In summary, the present study makes two main
contributions to the literature. First, we document
rates of comorbidity between specific behavior and
internalizing disorders and substance use disorders
in a community sample of adolescents, and impor-
tantly, differentiate depressive from anxiety dis-
orders in the presentation of these rates. Second, we
chart trajectories of illicit substance use from the age
of 12 to 22 in relation to specific comorbid disorders
at age 18. Together, these findings advance under-
standing of the developmental course of illicit sub-
stance use as well as substance use disorders.
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